Another study identified Akt as a constitutively active kinase that promotes survival of NSCLC cells and demonstrated that modulation of Akt activity by pharmacological or genetic approaches alters the cellular responsiveness to therapeutic modalities such as chemotherapy or radiotherapy [315]. Here, AKT1 is linked to non-small cell lung carcinoma.